ECZEMA
Clinical trials for ECZEMA explained in plain language.
Never miss a new study
Get alerted when new ECZEMA trials appear
Sign up with your email to follow new studies for ECZEMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill tested to tame severe eczema itch and rash
Disease control Recruiting nowThis study is testing a new oral medication called soquelitinib for adults with moderate to severe eczema (atopic dermatitis). About 200 participants will take either the drug or a placebo pill daily for 12 weeks to see if it safely reduces skin inflammation and itching. Doctors …
Matched conditions: ECZEMA
Phase: PHASE2 • Sponsor: Corvus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New hope for kids with severe eczema: major drug trial launches
Disease control Recruiting nowThis study is testing whether a medicine called abrocitinib can safely and effectively control moderate-to-severe eczema in children aged 6 to under 12. About 150 children will be randomly assigned to receive either the real medicine or a placebo (a look-alike pill with no medici…
Matched conditions: ECZEMA
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug trial offers hope for Tough-to-Treat eczema
Disease control Recruiting nowThis study is testing a new drug called IMG-007 to see if it can reduce the severity of eczema and is safe for adults with moderate-to-severe cases. It will compare different doses of the drug against a placebo (an inactive substance) in about 220 people over 52 weeks. The goal i…
Matched conditions: ECZEMA
Phase: PHASE2 • Sponsor: Inmagene LLC • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New eczema drug enters first human safety tests
Disease control Recruiting nowThis is the first study in humans testing a new drug called ARQ-234 for moderate to severe eczema (atopic dermatitis). Researchers will give single and multiple doses to healthy volunteers and people with eczema to check if it's safe, how the body processes it, and if it shows ea…
Matched conditions: ECZEMA
Phase: PHASE1 • Sponsor: Arcutis Biotherapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Tracking a promising eczema pill in everyday life
Disease control Recruiting nowThis study aims to see how well and safely the oral medication abrocitinib works for adults with moderate-to-severe eczema in real-world doctor's offices, not just controlled trials. About 183 participants will take the pill daily for up to 24 months while doctors track their ski…
Matched conditions: ECZEMA
Sponsor: Pfizer • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New cream tested to tame severe eczema itch and rash
Disease control Recruiting nowThis study is testing whether a new moisturizing cream called GX-03 can help control eczema symptoms better than a standard cream. About 100 adults with moderate to severe eczema will apply either GX-03 or a control cream twice daily for 8 weeks. Researchers will measure changes …
Matched conditions: ECZEMA
Phase: PHASE2 • Sponsor: Turn Therapeutics • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC
-
Could a friendly bacteria spray tame eczema itch?
Disease control Recruiting nowThis study is testing whether a spray containing a harmless skin bacteria (Roseomonas mucosa) mixed with ground cardamom seeds can help control eczema. About 120 people aged 2 and older with eczema will spray the solution on their skin 2-3 times a week for 14 weeks. Half will get…
Matched conditions: ECZEMA
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC
-
New drug trial seeks to tame severe eczema itch and rash
Disease control Recruiting nowThis study is testing an investigational drug called ATI-045 to see if it can reduce the skin rash and severe itching of moderate-to-severe eczema (atopic dermatitis). About 96 adults who haven't gotten enough relief from standard creams will receive either the drug or a placebo …
Matched conditions: ECZEMA
Phase: PHASE2 • Sponsor: Aclaris Therapeutics, Inc. • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC
-
Can a fish oil pill during pregnancy stop your Child's asthma?
Prevention Recruiting nowThis study is testing if taking a high dose of fish oil during pregnancy can prevent asthma and wheezing in young children. It will enroll 2,000 pregnant women with low omega-3 levels and give them either fish oil or a placebo pill from mid-pregnancy until after birth. Researcher…
Matched conditions: ECZEMA
Phase: PHASE3 • Sponsor: Professor Klaus Bønnelykke • Aim: Prevention
Last updated Mar 30, 2026 14:35 UTC
-
Can a gut health plan for C-Section babies prevent future allergies?
Prevention Recruiting nowThis study is testing whether personalized guidance based on a baby's gut bacteria can improve their gut health and potentially lower their risk of developing eczema and allergies. It will follow 250 healthy babies born by C-section for two years, providing some families with det…
Matched conditions: ECZEMA
Phase: NA • Sponsor: Seeding Inc • Aim: Prevention
Last updated Mar 24, 2026 12:02 UTC
-
Can a vitamin d boost during pregnancy shield kids from asthma?
Prevention Recruiting nowThis study is testing if giving pregnant women a higher dose of vitamin D can help prevent their children from developing asthma, persistent wheezing, and other related conditions like allergies and infections during early childhood. It will involve 2,000 pregnant women who will …
Matched conditions: ECZEMA
Phase: PHASE3 • Sponsor: Professor Klaus Bønnelykke • Aim: Prevention
Last updated Mar 23, 2026 15:19 UTC
-
New lotion tested for eczema relief
Symptom relief Recruiting nowThis study is testing a new moisturizing lotion to see if it safely improves eczema symptoms. About 15 adults in Malaysia with mild to moderate eczema will use the lotion for 4 weeks. Doctors will check their skin at the start and end to measure changes in dryness, redness, and o…
Matched conditions: ECZEMA
Phase: NA • Sponsor: USMARI Research & Innovation Centre • Aim: Symptom relief
Last updated Apr 01, 2026 14:41 UTC
-
Tracking Real-Life results for a common eczema medication
Knowledge-focused Recruiting nowThis study aims to observe how patients with moderate-to-severe atopic dermatitis (eczema) respond to the medication abrocitinib in real-world, everyday clinical practice. It will follow 200 patients aged 12 and older who are newly prescribed this medication by their doctor. Rese…
Matched conditions: ECZEMA
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC
-
Scientists probe how antibiotics reshape our Skin's hidden world
Knowledge-focused Recruiting nowThis study aims to understand how common eczema treatments, including antibiotics and bleach baths, change the community of bacteria living on the skin. Researchers will observe 130 healthy volunteers and people with moderate-to-severe eczema over one year, collecting skin sample…
Matched conditions: ECZEMA
Phase: PHASE2 • Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC
-
Scientists seek clues in blood and skin to fight itchy, serious rashes
Knowledge-focused Recruiting nowThis study aims to collect blood, urine, and skin samples from adults with specific skin conditions like cutaneous T-cell lymphoma, eczema, or atopic dermatitis. The purpose is to build a collection of samples for researchers to study. By analyzing these samples, scientists hope …
Matched conditions: ECZEMA
Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:18 UTC
-
Scientists map the invisible world on your skin
Knowledge-focused Recruiting nowThis study aims to understand the community of tiny organisms (like bacteria and fungi) that live on human skin. Researchers will compare the skin microbes of healthy people to those with moderate-to-severe eczema (atopic dermatitis) and some rare immune disorders. By taking skin…
Matched conditions: ECZEMA
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:26 UTC